跳至主要内容
临床试验/NCT03651882
NCT03651882已完成4 期

Intramyometrial and Intravenous Oxytocin Compared to Intravenous Carbetocin for Prevention of Postpartum Hemorrhage in Elective Cesarean Sections - a Monocentric Randomized Controlled Study

University of Zurich1 个研究点 分布在 1 个国家目标入组 550 人开始时间: 2018年8月7日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
550
试验地点
1
主要终点
incidence of women with a delta hemoglobin ≥ 30g/l.

研究概览

简要总结

Objective is to proof non-inferiority of intramyometrial and intravenous oxytocin application compared to intravenous carbetocin for prevention of postpartum hemorrhage in planned, uncomplicated cesarean deliveries.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • elective cesarean section
  • present informed consent
  • completed 36 weeks of gestation

排除标准

  • need for intubation (carbetocin is only licensed for epidural or spinal anesthesia)
  • multiple fetus pregnancy
  • known coagulopathy
  • Placenta praevia
  • morbidly adherent placenta
  • placental abruption
  • thrombocyte dysfunction
  • HELLP-syndrome
  • preeclampsia
  • history of uterine atony

研究组 & 干预措施

Oxytocin

Active Comparator

干预措施: Oxytocin (Drug)

Carbetocin

Active Comparator

干预措施: Carbetocin (Drug)

结局指标

主要结局

incidence of women with a delta hemoglobin ≥ 30g/l.

时间窗: 48 hours

Delta hemoglobin is defined as the difference of the hemoglobin at admission minus the hemoglobin after delivery, usually 24-48 hours after the delivery.

次要结局

  • adverse maternal outcome parameters(15 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验